Announcements Trials
Browse Landscape

Phase

Phase 2 6

Status

Completed 5Withdrawn 1

Sponsor Class

NIH 8OTHER 6INDUSTRY 5NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Gynecologic 1Dermatologic 1

Conditions

Rectal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Pancreatic Neoplasms 1Melanoma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Interventional × irofulven × Clear all
NCT00003441 2018-10-25

Irofulven in Treating Patients With Metastatic Colorectal Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
26 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00003666 2016-07-20

Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
36 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003786 2014-03-07

Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer

University of Chicago

Phase 2 Withdrawn
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00005070 2013-06-19

Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Gynecologic

Uterine Cervical Neoplasms

NCT00005968 2013-05-30

Irofulven in Treating Patients With Stage IV Melanoma

University of Colorado, Denver

Phase 2 Completed
Dermatologic

Melanoma

NCT00003760 2012-08-09

Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer

The University of Texas Health Science Center at San Antonio

Phase 2 Completed
3 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡